Orthogon Therapeutics, a privately held research and development (R&D) company, uses principles of biophysics and structure-based drug design to develop anti-infective small molecules that ...

Frontiers in Anti-Infective Agents Volume 5 is a collection ... His research work is focused on target-based drug design and synthesis, Methodology development, and development of nanomaterial ...

This has heightened the company’s core competencies in small-molecule drug design and synthesis and early development, resulting in a rich pipeline. Shionogi’s infectious disease portfolio of ...

AI can predict anti-infective medication activity, drug-target interactions, and therapeutic design. ML approaches to anti-infective drug discovery have centered on training models to identify new ...

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including ...

The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated ...

It offers different partnering models and is able to design and ... the focus of its anti-infective work. The agreement saw Sanofi transfer 100 employees, more than 10 drug candidates and € ...

The recent COVID pandemic has served to highlight the importance of developing effective treatments for infection, driving the recent resurgence in anti-infectives drug discovery and development of ...

The two anti-infective drug candidates should be superior in treating ... is the management team’s proprietary expertise in the design of highly potent compounds with extended lung retention ...

(AFP) New Delhi: Demand for anti-infective, gastro-intestinal and respiratory drugs grew by double digits in 2024 compared with the previous year at 17.2%, 10.7% and 19.2%, according to the Indian ...